Recent Finacing
Recent Raise
Breath Therapeutics develops inhaled drug/device therapies for severe respiratory diseases, producing a liposomal cyclosporine A formulation and an optimized eFlow nebulizer with remote adherence monitoring targeting bronchiolitis obliterans syndrome.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors